Thiago Carvalho
Follow

Promising but early (phase 2) data on a second generation of anti CD40L monoclonals for
My latest column for Nature Medicine.

nature.com/articles/d41591-023

· · 0 · 2 · 2
Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.

Trending now

Resources

Developers

What is Mastodon?

social.cleverlibre.org

More…

v3.5.19-qoto · Privacy policy